Key Partners

Canntrek logo
CannaTrek is a licensed cannabis producer focusing on low-cost, high-quality medical production in Australia, developing complete vertical integration with a similar business model.

Partnership Structure

CannaTrek benefits, leveraging CannTrust’s expertise in:

  • Greenhouse development & cultivation.
  • Call centre, detailing HCP.
  • Access to intellectual property and know-how.
  • Import of plant materials and finished product.

CannTrust benefits:

  • 19.8% ownership stake in CannaTrek 
(ability to maintain equity stake up to and including IPO).
  • First right of refusal on offtake for significant supply of low-cost product.
  • Access into Asian markets due to proximity and relations with Australia.
OCannabis logo
  • In 2018, CannTrust developed an exclusive partnership with O’Cannabis, Canada’s only nurse practitioner led medical cannabis clinic, providing accessibility through their online telemedicine portal for current and future patients.
  • O’Cannabis offers industry leading follow-up care and patient monitoring, ensuring patient compliance
Kindred logo
Breakthru Beverage Canada logo
  • Immediately following legalization in October 2018, CannTrust announced its partnership with Breakthru Beverage Group to develop our retail channel. Breakthru’s wholly owned subsidiary, Kindred, Canada’s #1 beverage alcohol distributor, represents CannTrust’s cannabis products to the Canadian adult consumer market, deploying a state-of-the-art route-to-market platform for CannTrust’s adult-use brands.
  • Our partnership with Kindred has allowed us to hit the ground running with 18 salespeople in the nine provinces where we have supply agreements, utilizing their proven business model, sales technology, infrastructure, and extensive relationships across Canada.
APOTEX - Innovating for patient affordability logo

CannTrust has established an exclusive relationship with Apotex that will be further advanced into 2019 and will include medical product development and leverage the Apotex distribution model.

National Access Cannabis logo
In 2018, CannTrust was one of four LP’s to secure preferred status and shelf space in NAC stores, which are set to open 200+ retail spaces. NAC is the largest private cannabis retailer in Canada to date, with 23 operational retail cannabis locations in Alberta and Manitoba, five additional locations throughout Manitoba planned for opening by the end of Q2 2019, and a planned expansion to Saskatchewan.


  • Collaborating with the leading pain experts at Michael G. DeGroote Pain Clinic of Hamilton Health Sciences and McMaster University on a double-blind, placebo-controlled trial to evaluate CannTrust’s range of cannabinoid-containing oil capsules for chronic non-cancer pain in more than 300 patients. This is the longest and largest trial of its kind to date.
  • CannTrust CBD Oil is being studied by Gold Coast University Hospital in Australia in one of the world’s first trials designed to determine whether cannabidiol may modify disease progression in Amyotrophic Lateral Sclerosis (ALS) or Motor Neuron Disease (MND). This randomized, double-blind, placebo-controlled clinical trial will also assess impact on study participant’s spasticity, pain, weight loss, and quality of life.


Since 2013 CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories.


Subscribe Now


© CannTrust 2019

Terms & Conditions | Accessibility

Pin It on Pinterest